This study investigated the use of CHEMEQRTM polymeric antimicrobial as a means of enhancing health and growth rates in broiler chickens. One-day-old Cobb-500 broilers were reared to 42 days. In trial 1, 100 birds received CHEMEQRTM polymeric antimicrobial via water, and 100 birds were untreated. Treated birds had significantly greater (P<0.0001) average daily gain (ADG), significantly lower (P<0.0016) feed conversion ratios, significantly lower (P<0.05) mortality, and a significantly lower (P<0.0042) viscosity of their ileal contents. In trial 2, three groups of 40 birds received reducing dosages of CHEMEQRTM polymeric antimicrobial, and a fourth group remained untreated. Groups receiving CHEMEQRTM polymeric antimicrobial had significantly greater (P<0.05) ADG, and two groups had significantly lower (P<0.05) feed conversion ratios than the controls. In trial 3, groups of 40 birds received either CHEMEQRTM polymeric antimicrobial, Salinomycin or Lasalocid in-feed, or were untreated. Birds receiving CHEMEQRTM polymeric antimicrobial had significantly greater (P<0.05) ADG than those receiving Salinomycin. CHEMEQRTM polymeric antimicrobial helped to maintain the health and to improve the growth performance of broiler chickens.
No takes yet. Share an insight, caveat, or question.
Hampson et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: